9-5300385-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_134441.3(RLN2):āc.271G>Cā(p.Val91Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000608 in 1,612,752 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_134441.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000487 AC: 74AN: 151920Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000533 AC: 133AN: 249426Hom.: 0 AF XY: 0.000668 AC XY: 90AN XY: 134674
GnomAD4 exome AF: 0.000620 AC: 906AN: 1460712Hom.: 1 Cov.: 31 AF XY: 0.000621 AC XY: 451AN XY: 726536
GnomAD4 genome AF: 0.000487 AC: 74AN: 152040Hom.: 0 Cov.: 32 AF XY: 0.000484 AC XY: 36AN XY: 74310
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 15, 2021 | The c.271G>C (p.V91L) alteration is located in exon 2 (coding exon 2) of the RLN2 gene. This alteration results from a G to C substitution at nucleotide position 271, causing the valine (V) at amino acid position 91 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at